Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Threshold Pharmaceuticals Inc (NASDAQ:THLD)

0.5159
Delayed Data
As of 3:58pm ET
 +0.0008 / +0.16%
Today’s Change
0.21
Today|||52-Week Range
1.48
+16.98%
Year-to-Date

Today’s Trading

Previous close0.52
Today’s open0.51
Day’s range0.50 - 0.54
Volume518,167
Average volume (3 months)1,265,541
Market cap$36.9M
Dividend yield--
Data as of 3:58pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-166.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+422.45%
P/E ratio0.8
Price/Sales0.46
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
TPIVTapImmune Inc-0.05-1.13%
RPRXRepros Therapeutics ...-0.03-2.16%
FCSCFibrocell Science In...-0.02-2.73%
IMMYImprimis Pharmaceuti...+0.03+1.14%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$76.9M
Annual profit (last year)$43.8M
Net profit margin56.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Harold E. Selick
Vice President-
Clinical Operations
Kristen Quigley
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs